Mineralocorticoid receptor antagonists in heart failure with sustained monomorphic ventricular tachycardia: comparative analysis of spironolactone versus eplerenone.@drkarthik2010@BoopathyCardio@SanjitSJolly@hfaimedia
https://t.co/lt6JSBiIdJ
A p-value below the noninferiority threshold is not a free pass. Noninferiority margins need clinical justification, and intention-to-treat and per-protocol analyses should ideally point in the same direction. As DES outcomes continue to improve, noninferiority trials of coronary devices become increasingly fragile.
Congratulations to Dr C Narasimhan sir for the Lifetime Achievement Award at the HRS 2026! Richly deserved for having pioneered EP & for inspiring & training so many cardiologists!
(Pic courtesy: @greatbong)
#cardiotwitter#epeeps
Impact of invasive coronary function testing on management of ANOCA
patients and secondary care resource utilisation: insights from a multicentre
retrospective study in the UK. @BHIBristol@RUHBath@drkarthik2010@BoopathyCardio
https://t.co/Vxlx5PHMyh